Cronos Group Inc. filings document operating results, governance matters, capital structure and material events for a British Columbia-based cannabis issuer. Form 8-K reports include financial-results releases, material agreements, regulatory disclosures, capital-structure items and changes involving finance leadership or principal accounting responsibilities.
Proxy and shareholder-meeting filings describe director elections, executive compensation votes, auditor appointments, board governance and voting results. The filing record also reflects the company’s public-company reporting framework for its cannabis brand portfolio, including Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, and the governance disclosures associated with its common shares listed under CRON.
James D. Rudyk, a director of Cronos Group Inc. (CRON), acquired 66,079.3 Deferred Share Units (DSUs) on 08/07/2025. Each DSU entitles the reporting person to receive a lump-sum cash payment equal to the fair market value of one common share upon redemption. The filing shows the number of common-share equivalents beneficially owned following the reported transaction as 313,882.29, held directly. The filing also states that vested DSUs are mandatorily redeemed by the company on the first trading day after the reporting person ceases to be a director.
Jason Marc Adler, identified as a director of Cronos Group Inc. (CRON), reported a transaction dated 08/07/2025 in which he acquired 66,079.3 Deferred Share Units (DSUs). The filing shows 66,079.3 DSUs underlying 66,079.3 common shares and reports beneficial ownership of 313,882.29 common shares following the reported transaction, held in a direct ownership form.
The filing explains that upon redemption DSUs pay a lump-sum cash amount equal to the fair market value of Cronos common shares on the redemption date. It also states that vested DSUs are mandatorily redeemed by the company on the first trading day after the reporting person ceases to be a director.
Murray R. Garnick, a director of Cronos Group Inc. (CRON), acquired 66,079.3 deferred share units on 08/07/2025 and reported direct beneficial ownership of 130,734.47 common shares following the transaction.
Deferred share units entitle the holder to a lump sum cash payment equal to the fair market value of Cronos common shares on redemption, and vested units are mandatorily redeemed by the company on the first trading day after the reporting person ceases to be a director.
Cronos Group insider Lloyd A. Wilson filed an initial Form 3 disclosing direct beneficial ownership of 10,500 common shares of Cronos Group Inc. (CRON). The filing identifies the reporting person as an officer with the title VP, Controller and reports no derivative securities. This Form 3 establishes the reporter's baseline public ownership position for future Section 16 disclosures.
On 7 Aug 2025 Cronos Group Inc. (NASDAQ: CRON) filed a Form 8-K disclosing two matters:
- Item 2.02 – Results of Operations: the company issued a press release (Exhibit 99.1) containing its Q2-2025 financial results for the period ended 30 Jun 2025. Specific revenue, earnings or guidance figures are not included in the 8-K body; investors must refer to the attached exhibit for details.
- Item 5.02 – Officer change: effective immediately after the forthcoming Form 10-Q, the Board appointed Lloyd Wilson (53), currently Vice President & Controller, as Principal Accounting Officer. Wilson brings 20+ years of GAAP and SEC-reporting experience, most recently as Corporate Controller at Vital Farms (Nov 2021–Jun 2025) and previously as an auditor at Grant Thornton and KPMG. He replaces James McGinness, who departs the company on the same date.
The filing notes no family relationships, related-party transactions or special arrangements tied to Wilson’s selection. Other sections are routine, and no forward-looking guidance was provided.